The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis.

Wenwu He,Chenghao Wang,Changding Li,Xin Nie,Haojun Li,Jialong Li, Na Zhao,Haijun Chen, Xiaojie Miao,Yongtao Han,Lin Peng,Xuefeng Leng

Frontiers in Immunology（2023）

引用 0|浏览1

暂无评分

摘要

Neoadjuvant immunotherapy has good efficacy and safety profiles in patients with locally advanced ESCC. Additional RCTs with long-term survival data are warranted.

查看译文

关键词

esophageal squamous cell carcinoma,meta-analysis,nICRT,nICT,neoadjuvant immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要